We are live on
!
Find out more
AbCellera Biologics
ABCL
ABCL
129 hedge funds and large institutions have $280M invested in AbCellera Biologics in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 51 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
3.51% more ownership
Funds ownership: 38.56% → 42.08% (+3.5%)
12% less funds holding
Funds holding: 146 → 129 (-17)
16% less capital invested
Capital invested by funds: $334M → $280M (-$53.8M)
26% less call options, than puts
Call options by funds: $682K | Put options by funds: $927K
37% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 51
56% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 27
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
129
Holders Change
-17
Holders Change %
-11.64%
% of All Funds
1.73%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
32
Reduced
51
Closed
27
Calls
$682K
Puts
$927K
Net Calls
-$245K
Net Calls Change
+$82K
Top Buyers
| 1 |
UBS AM
Chicago,
Illinois
|
+$32M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$15.6M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$8.91M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.49M |
| 5 |
Renaissance Technologies
New York
|
+$1.17M |
Top Sellers
| 1 |
PM
Prosight Management
Dallas,
Texas
|
-$13M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$2.98M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.83M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$1.87M |
| 5 |
Millennium Management
New York
|
-$1.76M |